The global Unnatural Amino Acids Market was valued at US$ 2.16 billion in 2024, expected to reach US$ 5.03 billion by 2032, with a CAGR of 11.15%. The United States market was valued at US$ 0.65 billion in 2024, projected to reach US$ 1.42 billion by 2032, driven by FDA-supported peptide therapeutics innovations and biopharmaceutical R&D investments.
Companies like Ajinomoto, BASF, and Sen Chemicals are accelerating innovations in the market, with a focus on drug discovery, biological development, and protein engineering. Outsourcing to biological and pharmaceutical companies is further boosting the global market growth. The increased use of unnatural amino acids in next-gen treatments is a key factor driving expansion.
Unnatural amino acids, beyond the 20 natural amino acids, play a critical role in developing customized proteins and advanced drug candidates. Advancements in biosynthetic engineering and chemical synthesis have enabled mass production of these amino acids, enhancing efficiency and cost-effectiveness. The demand for novel therapies is increasing, with these compounds supporting targeted drug delivery and gene therapy.
In 2024, D-amino acids & derivatives dominated the market, while Modified/Functionalized Amino Acids emerged as the fastest-growing segment. Pharmaceuticals and drug development accounted for over 35% of the market share for unnatural amino acids, with Cosmetics & Personal Care as the fastest-growing application segment. Synthetic (Chemical Synthesis) led the market in 2024, with Microbial/biosynthetic sources as the fastest-growing segment.
North America led the global unnatural amino acids market in 2024 due to its strong biotechnology and pharmaceutical infrastructure. Asia Pacific is the fastest-growing region, driven by contract manufacturing activities, biopharma R&D outsourcing, and the expanding food and cosmetics industries. Recent developments include BASF SE’s expansion of synthetic amino acid production and Suzhou Highfine Biotech Co., Ltd.’s launch of high-purity unnatural amino acids.
Exclusive sections of the report cover R&D investment and funding trends, technology integration trends, clinical trials and pipeline progression metrics, diagnostic and treatment penetration rates, and public-private and regulatory-backed initiatives. These insights help understand the investment landscape, technological advancements, clinical applications, market adoption, and collaborative initiatives in the unnatural amino acids market. The Unnatural Amino Acids Market Report outlines key details for 2024, with a market size of USD 2.16 billion expected to reach USD 5.03 billion by 2032, showing a CAGR of 11.15% from 2025 to 2032. The report covers various segments like types, applications, sources, and end-users, with regional analysis including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
SNS Insider offers access to the complete details of the Unnatural Amino Acids Market Analysis & Outlook report. For more information or customization options, contact [email protected]. The company aims to provide clients with up-to-date market data, consumer insights, and opinions to make informed decisions in a rapidly changing environment. Through surveys, video talks, and focus groups, SNS Insider ensures clients have the knowledge needed to navigate the market effectively.
Read more at GlobeNewswire: Unnatural Amino Acids Market to Reach US$ 5.03 Billion By